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Abstract 
The use of medicinal plants for medicine has been prevalent since ancient times and 
various plants are used for public health. One of the plants that is often used in herbal 
medicine is celery, either directly in the form of vegetables or as an extract from the 
Apium graveolens L plant. Celery extract has previously been given to white mice, and 
can significantly protect the gastric mucosa and suppress gastric acid secretion. 
Traditional medicine derived from plant extracts is generally more desirable in tablet or 
capsule dosage forms. The objective of this study is to determine the best filler in the 
celery herb extract capsule formulation. This study used a pure experimental method 
using celery herb extracts which were formulated in capsule dosage forms. The powder 
fillers used in this formulation are Avicel 101, Avicel 102, and Amylum maydis. The 
extract capsules were then evaluated for uniformity of weight and disintegration time. 
Based on the evaluation results, the capsules formulated with Avicel 102 filler gave the 
best results with an average weight uniformity of 380.98 ± 4.41 mg and disintegration 
time of 2.64 ± 0.31 minutes. It is advisable to continue the evaluation of the dissolution 
test for the capsule preparation which gives the best result. 
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The use of medicinal plants for medicine has been prevalent since ancient times and 
various plants are used for public health. Medicinal plants have fewer side effects than 
chemical drugs (Kooti, et al., 2014). Currently, herbal medicines are used as an alternative 
to chemical drugs and the main reason is their low side effect rate compared to chemical 
drugs (Zaheer-Ud-Din, et al., 2012; Qusaj, et al., 2012). 
One of the plants that is often used in herbal medicine is celery, either directly in 
the form of vegetables or as an extract from the Apium graveolens L. Thus, it has the 
potential to be developed as an alternative treatment that is safer and more affordable than 
synthetic drugs. 
In a previous study conducted by Putri in 2015, testing on mice showed that celery 
extract provides antiulcer activity, which can significantly prevent gastric ulcers by 
decreasing the ulcer index (Putri, 2015). The content of celery (Apium graveolens) in the 
form of D-limonene and flavonoids which can act as antioxidants and anti-inflammatory 
and have an effect in reducing ulceration intensity in the stomach so that celery has the 
potential to be used to prevent damage to the stomach (Kooti, et al., 2014; Powanda, et 
al., 2015; Yu, et al., 2017; AlHowiriny, et al., 2015). Celery extract at a dose of 300 mg/kg 
showed a significant inhibitory effect on gastric lesions (91-95%), this is equivalent to 
the effect provided by omeprazole (94%) (Baananou, et al., 2013; Brankovic, et al., 2015). 
Traditional medicine derived from plant extracts is generally in demand by the 
public in tablet or capsule dosage forms. Plant extracts that tend to have unpleasant tastes 
and odors can be overcome by formulating them in capsule dosage form (Al Tabakha, et 
al., 2015; Gulapalli & Mazetalli, 2017; Qusaj, et al., 2012; Patet & Amin, 2013; Lau, 
2018; El, et al., 2012). But the problem is the consistency of the thick extract will affect 
the stability of the capsule preparation. In general, capsules can be powder or granule. To 
simplify the process of filling capsules, the contents of the capsules are made in powder 
form with the addition of fillers, lubricants, and glidants (Kemenkes, R.I., 2014; Amidon, 
et al., 2015; Darji, et al., 2018; Qusaj, et al., 2012, Stranzinger, et al., 2017). 
The capsule formulation containing extracts with a thick consistency and high-
water content requires special treatment to produce good capsules. Therefore, it is 
necessary to have excipients or additives capable of adsorbing or absorbing water and can 
improve the properties of powder flow. Avicel is an excipient that can be used as a filler 
which also functions as an adsorbent. The addition of Aerosil to the formulation is 
expected to maintain the hygroscopicity of capsules (Agoes, 2007; Gajdziok, et al., 2011; 
Darji, et al., 2018; Stanzinger, 2017; Qusaj, et al., 2012). To obtain a capsule mass with 
a good flow rate a suitable filler can be added, such as Avicel 101 and Avicel 102. 
Generally, Avicel is used in the pharmaceutical field, especially as a filler in tablet and 
capsule formulas. Avicel also has lubricant and disintegrate properties (Rowe, 2009; 
Barbosa, et al., 2019; Darji, et al., 2018; Stanzinger, 2017). Avicel 101 has a smaller 
particle size so that it is able to adsorb moisture. Avicel 102 has a larger particle size so 
it is useful for improving flow properties (Agoes, 2008; Darji, et al., 2018). Another filler 
used is starch. Starch maydis is widely used as a filler because of its small hygroscopicity. 
Magnesium stearate and talc can be used as a lubricant (Rowe, 2009; Barbosa, et al., 
2019; Darji, et al., 2018; Stanzinger, 2017). This study aims to find the best filler in the 
thick capsule formulation of celery herb. The powder fillers used in this formulation are 
Avicel 101, Avicel 102 and starch maydis. 
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2. RESEARCH METHOD 
The method used is a pure experimental method using celery herb extract as an 
antiulcer drug at a dose of 336 mg/70 kg BB obtained from the research of Baananou, et 
al, 2013. The extract is made in capsules with fillers Avicel 101, Avicel 102 and starch 
maydis which is mixed in the thick extract of celery herbs in a ratio of 1:1. The complete 
capsule formula is as shown in Table 1. The study has received Ethical Approval from 
the Health Research Ethics Commission of the Health Polytechnic of the Ministry of 
Health of Tasikmalaya No. 2019/KEPK/PE/VII/0008.  
Table 1.  Formulations for capsules made 
Component 
Formula 
F1 F2 F3 
Celery herb extract 336 mg 336 mg 336 mg 
Avicel 101 336 mg - - 
Avicel 102 - 336 mg - 
Amilum maydis - - 336 mg 
Lactosa 33 mg 33 mg 33 mg 
Aerosil 3 % 3 % 3 % 
Talk 2 % 2 % 2 % 
Mg Stearat 1 % 1 % 1 % 
Capsule weight 750 mg 750 mg 750 mg 
The formulation of celery herb extract capsules was made in 3 formulas, which 
were formula 1 with Avicel 101 filler, formula 2 with Avicel 102 filler and formula 3 
with starch maydis filler. Formulations were made with a variety of fillers and other 
additives used are fixed (Augsburger, 2000; Barbosa, et al., 2019; Darji, et al., 2018; 
Gullapalli & Mazzitelli, 2017; Stanzinger, et al., 2017). 
 
3. RESULTS AND DISCUSSION 
a. Celery Extract Making  
Celery herb comes from agricultural areas in Lembang, West Bandung Regency. 
Herba Celery has been determined at the University of Siliwangi, Tasikmalaya. Celery 
was extracted using the maceration method with 96% ethanol solvent for three times 24 
hours with occasional stirring at each solvent change. The choice of this maceration 
method was used because of the secondary metabolites that were not heat resistant, which 
were flavonoids because flavonoid compounds are easily oxidized at high temperatures. 
Cold extraction allows many compounds to be extracted, although some compounds 
cannot use the maceration method. Celery extract was concentrated using a ratory 
evavorator. Concentration was done to separate the solvent, so that a thick extract was 
obtained. The yield obtained from the extraction and concentration was 3.56%. The size 
of the yield shows whether or not the extraction is effective. The effectiveness of 
extraction can be influenced by several things, namely the type of solvent, the extraction 
method used, the particle size of the dadap leaf powder and the length of the extraction 
time (Baananou, et al., 2013). 
Phytochemical screening tests on concentrated extracts were carried out to 
determine what secondary metabolites were present in the extract. The test method and 
secondary metabolite reagents are in accordance with the book from the Indonesian 




Table 2. Results of Phytochemical Screening Test 





Flavonoid Mg+ HCl pekat + 
Tanin FeCl3 1% + 
Saponin Aquadest + HCl + 
Steroid Liebermann - 
Information : +  = There are secondary metabolites 
-  = There are no secondary metabolites 
The results of phytochemical screening of celery herb extracts showed that celery 
extract contained secondary metabolites of flavonoids, tannins and saponins. 
 
b.    Celery Extract Capsule Formulation  
In making celery extract capsules, it begins with a literature study to calculate the 
dosage of celery extract used for anti-ulcer treatment in humans. In addition, to 
therapeutic doses, a toxic dose literature study was also conducted to clarify that the 
therapeutic dose of celery extract as an anti-ulcer to be formulated in capsule form does 
not exceed the toxic dose, where it is known that the toxic dose of celery extract is 2500 
mg/kg BW (Aini, L.N, 2017). 
After determining the dosage, 3 formulas of celery extract powder were made using 
Avicel 101, Avicel 102 and Amylum maydis fillers with a ratio of 1: 1 for each extract 
and filler. 
Capsules are made conventionally in all formulas both with Avicel 101, Avicel 102 
and Amylum maydis fillers. The conventional method was chosen because it has the 
advantage of being more economical, increasing the optimization of capsule 
disintegration because it immediately becomes fine particles so that the disintegration 
time is faster, the absorption rate increases and increases bioavailability (BPOM, 2010; 
El, et al., 2012; Charoo, et al., 2017). The excipient used was selected based on the 
properties of the excipient which had good flow and compressibility properties and was 
able to absorb a lot of water (Nugroho, 2012; Darji, et al., 2018; Stranzinger, et al., 2017). 
The weight of the capsules as in table 1 is made of 750 mg per capsule of 200 capsules.  
 















F1 2,03 ± 0,17 0,38 0,45 13,92 33,33 
F2 2,17 ± 0,17 0,41 0,45 10,29 25,00 
F3 1,95 ± 0,18 0,37 0,44 15,85 45,54 
Information:  F1 = capsules with Avicel 101 fillers 
F2 = capsules with Avicel 102 fillers 
F3 = capsules filled with Amylum maydis  
In the process of making celery extract capsules, the mass of the capsules is 
evaluated. From the results of the evaluation, the flow properties, compressibility index 
and angle of rest of the capsule mass with Avicel 102 (F2) filler were 10.29% and 25.00αO 
had better values compared to the mass of other celery extract capsules with Avicel 101 
fillers (F1 ) of 13.92% and 33.33αO and fillers of amylum maydis (F3) of 15.85% and 
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45.54 αO. This can be caused by differences in the types and properties of fillers. For the 
mass of the F2 celery extract capsule, Avicel 102 filler in the form of granules was used, 
while for the mass of the F1 and F3 celery extract capsules, Avicel 101 and amylum 
maydis were used respectively. 
To see the mass homogeneity of the capsule, a microscope was tested. The 
homogeneity of the capsule mass is important because it will affect the dosage per 
capsule. 
   
Figure 1. Homogeneity test results using a 500X magnification microscope 
After evaluating the mass of the capsule, the capsule mass is inserted into the 
capsule shell using the capsule shell number that corresponds to the compressed density 
value of each formula, which is the capsule shell number 0 with a volume capacity of 
0.68 mL and an compressive density of 0.544 g/mL. Furthermore, the quality of the celery 
extract capsules was evaluated.  
 
Table 4.  Evaluation Results of Celery Extract Capsules with Avicel 101, Avicel 102 and 












Test 25oC, RH 
70% (Day) 
F1 376,68 ± 13,60 472,44 ± 13,60 3,62 ± 0,40 90 
F2 380,98 ± 4,41 476,74 ± 4,41 2,64 ± 0,31 90 
F3 377,42 ± 10,56 473,18 ± 10,56 2,88 ± 0,42 90 
Table 4 shows that the capsules made with Avicel 101 fillers have a higher weight 
variation (376.68 ± 13.60 mg) than the weight of celery extract capsules with Avicel 102 
fillers and celery extract capsules with Amylum maydis filler with an average weight of 
each. the capsules were 380.98 ± 4.41 mg and 377.42 ± 10.56 mg respectively. The 
variation in capsule weight was caused by the poor mass flow properties of the capsules 
with Avicel 101 fillers and the unfavorable mass of the capsules with Amylum maydis as 
the filler, which are 2.03 g/sec and 1.95 g/sec, while the best flow properties were seen in 
the mass of the capsules of celery extract with Avicel 102 filler is 2.17 g/minute 
(Hadisoewignyo & Fudholi, 2013; Gajdziok, et al., 2011; Stranzinger, et al., 2017). 
Celery extract capsules with Avicel 102 fillers have good flow properties and small 
weight variations because the shape of Avicel 102 is granular so that it has high porosity 
which absorbs moisture well and has high compressibility properties compared to Avicel 
101 and Amylum maydis which are in powder form (Narang & Boddu, 2015; Gajdziok, 
et al., 2011; Stranzinger, et al., 2017). Flow properties will affect the uniformity of 











   
Figure 2. Result of Hygroscopicity Test for 3 months of storage 
Figure 1 shows the hygroscopicity test applied on celery extract capsules of all 
formulas, where the capsules are stored in containers and packages used for storage and 
stored under controlled room conditions with a temperature of 25oC and 70% humidity. 
This hygroscopicity test was performed to determine how long the celery extract capsules 
were stable on storage. The results of the hygroscopicity test carried out for 3 months 
showed that all of the capsule formulas of celery extract were stable in tightly closed 
containers at 25oC and 70% humidity. 
 
4. CONCLUSION 
The capsule formulation of thick celery herb extracts made with Avicel 101, Avicel 
102 and Amilum maydis fillers produces good and stable capsules. Based on the 
evaluation results, the capsules formulated with Avicel 102 filler gave the best results 
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